Summary
- Current Price
- As of today, NVCT price is $21.52, down -5.45% on
- Current Price All-Time High
- NVCT price is currently -26.49% below its historical high of $29.28 set on
- Market Cap
- NVCT current market cap is $678M, up +308.23% over the past 365 days
- Revenue
- NVCT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for NVCT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Nuvectis Pharma, Inc. |
| Ticker | NASDAQ: NVCT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | nuvectis.com |
| Employees | 13 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $21.52 | |
| Price, 1D Change | -5.45% | |
| $678M | ||
| - | ||
| - | ||
| 1.25 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.32 | ||
| EPS, 1Y Change | -19.21% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.32 | ||
| EPS Estimate | N/A | -$1.01 |
| EPS Est. Change | N/A | +23.84% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $21.52 | |
| Price Target | - | $33.00 |
| Price Tgt. Change | - | +53.35% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.01 | -$1.11 | -10.29% | |
| -$1.31 | -$1.32 | -0.88% | |
| -$1.01 | N/A | +23.84% | |
| -$1.01 | N/A | +23.39% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $21.52 | |
| $10.04 | ||
| $16.18 | ||
| $11.56 | ||
| $16.99 | ||
| $1.16 | ||
| 1.25 | ||
| $1.64 | ||
| 59.76 | ||
| 82.25% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.32 | ||
| $0.00 | ||
| - | ||
| -$27.57M | ||
| - | ||
| -$28.87M | ||
| - | ||
| -$27.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 2.38 | ||
| 2.38 | ||
| - | ||
| - | ||
| 24.04 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 47.71 | ||
| -23.11 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $18.41M | ||
| $31.63M | ||
| $31.71M | ||
| $31.71M | ||
| $13.30M | ||
| $13.30M | ||
| $0.00 | ||
| $0.00 | ||
| $6.27M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $28.87M | ||
| $27.57M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$16.01M | ||
| $0.00 | ||
| $29.11M | ||
| $0.00 | ||
| -$16.01M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Roth Capital | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Maxim Group | ||
| Laidlaw & Co. | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with NVCT
FAQ
- What is the ticker symbol for Nuvectis Pharma, Inc.?
- The ticker symbol for Nuvectis Pharma, Inc. is NASDAQ:NVCT
- Does Nuvectis Pharma, Inc. pay dividends?
- No, Nuvectis Pharma, Inc. does not pay dividends
- What sector is Nuvectis Pharma, Inc. in?
- Nuvectis Pharma, Inc. is in the Healthcare sector
- What industry is Nuvectis Pharma, Inc. in?
- Nuvectis Pharma, Inc. is in the Biotechnology industry
- What country is Nuvectis Pharma, Inc. based in?
- Nuvectis Pharma, Inc. is headquartered in United States
- When did Nuvectis Pharma, Inc. go public?
- Nuvectis Pharma, Inc. initial public offering (IPO) was on February 4, 2022
- Is Nuvectis Pharma, Inc. in the S&P 500?
- No, Nuvectis Pharma, Inc. is not included in the S&P 500 index
- Is Nuvectis Pharma, Inc. in the NASDAQ 100?
- No, Nuvectis Pharma, Inc. is not included in the NASDAQ 100 index
- Is Nuvectis Pharma, Inc. in the Dow Jones?
- No, Nuvectis Pharma, Inc. is not included in the Dow Jones index
- When was Nuvectis Pharma, Inc. last earnings report?
- Nuvectis Pharma, Inc.'s most recent earnings report was on May 5, 2026
- When does Nuvectis Pharma, Inc. report earnings?
- The next expected earnings date for Nuvectis Pharma, Inc. is August 4, 2026
Data Sources & References
- NVCT Official Website www.nuvectis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1875558/000110465926013044/0001104659-26-013044-index.htm
- NVCT Profile on Yahoo Finance finance.yahoo.com/quote/NVCT
- NVCT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvct